EP1539957A4 - Nouvelles methodes de diagnostic et de therapie et reactifs correspondants - Google Patents
Nouvelles methodes de diagnostic et de therapie et reactifs correspondantsInfo
- Publication number
- EP1539957A4 EP1539957A4 EP03793494A EP03793494A EP1539957A4 EP 1539957 A4 EP1539957 A4 EP 1539957A4 EP 03793494 A EP03793494 A EP 03793494A EP 03793494 A EP03793494 A EP 03793494A EP 1539957 A4 EP1539957 A4 EP 1539957A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- therapeutic methods
- novel diagnostic
- reagents therefor
- therefor
- reagents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/9015—Ligases (6)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002951346 | 2002-09-05 | ||
AU2002951346A AU2002951346A0 (en) | 2002-09-05 | 2002-09-05 | Diagnosis of ovarian cancer |
US42521802P | 2002-11-07 | 2002-11-07 | |
US425218P | 2002-11-07 | ||
PCT/AU2003/001164 WO2004022750A1 (fr) | 2002-09-05 | 2003-09-05 | Nouvelles methodes de diagnostic et de therapie et reactifs correspondants |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1539957A1 EP1539957A1 (fr) | 2005-06-15 |
EP1539957A4 true EP1539957A4 (fr) | 2006-10-11 |
Family
ID=31979115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03793494A Withdrawn EP1539957A4 (fr) | 2002-09-05 | 2003-09-05 | Nouvelles methodes de diagnostic et de therapie et reactifs correspondants |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1539957A4 (fr) |
JP (1) | JP2005537790A (fr) |
CA (1) | CA2497873A1 (fr) |
WO (1) | WO2004022750A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200639253A (en) | 2005-02-01 | 2006-11-16 | Alcon Inc | RNAi-mediated inhibition of ocular targets |
IL177006A0 (en) * | 2005-08-02 | 2006-12-10 | Veridex Llc | Predicting bone relapse of breast cancer |
JP2008297257A (ja) * | 2007-05-31 | 2008-12-11 | St Marianna Univ School Of Medicine | 消化器癌の新規治療薬 |
CN101429540B (zh) * | 2007-11-09 | 2013-07-10 | 北京雅康博生物科技有限公司 | 实时定量pcr检测细胞周期蛋白b2基因表达的方法 |
CN102559601B (zh) * | 2012-01-13 | 2014-09-03 | 清华大学 | 用于鉴定肿瘤细胞或肿瘤组织的crept抗体 |
WO2014038524A1 (fr) * | 2012-09-05 | 2014-03-13 | 和光純薬工業株式会社 | Procédé de dépistage du cancer du sein |
-
2003
- 2003-09-05 JP JP2004533072A patent/JP2005537790A/ja not_active Withdrawn
- 2003-09-05 CA CA002497873A patent/CA2497873A1/fr not_active Abandoned
- 2003-09-05 WO PCT/AU2003/001164 patent/WO2004022750A1/fr active Application Filing
- 2003-09-05 EP EP03793494A patent/EP1539957A4/fr not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
WO2004022750A1 (fr) | 2004-03-18 |
JP2005537790A (ja) | 2005-12-15 |
CA2497873A1 (fr) | 2004-03-18 |
EP1539957A1 (fr) | 2005-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0418542D0 (en) | Integrated biosensor and simulation system for diagnosis and therapy | |
EP1572131A4 (fr) | Therapie fondee sur les anticorps | |
EP1572741A4 (fr) | Agents diagnostiques et therapeutiques | |
AU2003268457A8 (en) | Biomap analysis | |
AU2002303261A8 (en) | Gene brcc2 and diagnostic and therapeutic uses thereof | |
GB0308382D0 (en) | Therapeutic methods and means | |
EP1532173A4 (fr) | Analyse de proteines | |
AU2003226899A8 (en) | Human diabetes-mediating proteins | |
EP1539957A4 (fr) | Nouvelles methodes de diagnostic et de therapie et reactifs correspondants | |
GB0326578D0 (en) | Cancer diagnosis and therapy | |
HK1094531A1 (en) | P185neu-encoding dna and therapeutical uses thereof | |
GB0722767D0 (en) | Integrated biosensor and simulation system for diognosis and therapy | |
GB0212581D0 (en) | Medical analysis device | |
GB0200757D0 (en) | Diagnostic methods | |
EP1569928A4 (fr) | Composes et methodes therapeutiques | |
GB0229444D0 (en) | Diagnostic method and assay kit | |
EP1483407A4 (fr) | Methodes therapeutiques et diagnostiques | |
EP1412754A4 (fr) | Procede et agents diagnostiques | |
EP1567863A4 (fr) | Procedes de therapie et de diagnostic | |
AU2003231937A8 (en) | Therapeutic methods | |
GB0217912D0 (en) | Diagnosis and assay methods | |
AU2002367463A8 (en) | Novel p53bp2 compounds for therapy and diagnosis and methods for using same | |
AU2003270518A8 (en) | Therapeutic anti-bgp(c-cam1) antibodies and uses thereof | |
GB0313625D0 (en) | Therapeutic and assay methods | |
GB0214842D0 (en) | Diagnostic method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050324 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060908 |
|
17Q | First examination report despatched |
Effective date: 20070213 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20081209 |